PhoenixBio, a Hiroshima University-originated biotech venture, provides contract testing services, primarily in the United States, using PXB mice and other products. It plans to reorganize its drug-discovery support structure through expanded service offerings and M&A.
PhoenixBio is a Hiroshima University-originated biotech venture that provides contract testing services primarily in the United States using PXB mice.
The company is expanding its lineup of contract testing services and promoting sales of PXB mice and PXB-cells.
Going forward, it plans to pursue business reorganization through M&A to reorganize its drug-discovery support operations.
The article states 2026/09/30 as the date of publication.